Company: MBVI
Filing Date: 2025-07-02
Form Type: DRS
Source: 0001213900-25-060580
Chunk: 8

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-07-02
Form: DRS
Chunk 8
---
.45 per unit on units other than those sold pursuant to the underwriters’ option to purchase additional units and $0.65 per unit on units sold pursuant to the underwriters’ option to purchase additional units, or $13,500,000 in the aggregate or up to $16,425,000 in the aggregate if the underwriters’ over -allotmentoption is exercised in full, payable to Cantor Fitzgerald & Co. for deferred underwriting commissions to be deposited into a trust account located in the United States and released to Cantor Fitzgerald & Co. for its own account only upon the completion of an initial business combination. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters.

Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $300 million, or $345 million if the underwriter’s overallotment option is exercised in full ($10.00 per unit in either case), will be placed into a U.S. -basedtrust account with Continental Stock Transfer & Trust Company acting as trustee. Because our sponsor acquired the founder shares at a nominal price, our public shareholders will incur an immediate and substantial dilution upon the closing of this offering, assuming no value is ascribed to the warrants included in the units. Further, the Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti -dilutionrights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion. See “ Risk Factors — Risks Relating to our Securities — The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline.” The following table illustrates the difference between the public offering price per unit and our net tangible book value per share (“NTBV”), as adjusted to give effect to this offering and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over -allotmentoption. See “ Dilution.”

| As of June 10, 2025 |                                                 |     |                |